Gene · 6607
NIH grants1,484
NIH grants whose papers are about the gene, through NIH's grant-paper links.
381 to 400 of 1,484
Download this page as JSON| Grant | Title | SMN2 papers | Newest fiscal year |
|---|---|---|---|
| R01CA243445 | Nano-Engineered Lab-on-a-Chip for Assessing HuR-Regulated Exosomes for Cancer Monitoring and Targeted Therapy | 1 | 2023 |
| R01EY025536 | Photoreceptor neuron specific alternative splicing messenger RNA | 1 | 2023 |
| R01GM120309 | SCF Ubiquitin Ligases in Cell Cycle Control and Chromosome Stability | 1 | 2023 |
| R01GM130738 | Investigating the co-transcriptional impact of genetic variation on gene regulation and disease | 1 | 2023 |
| R01GM134104 | Extracellular matrix sensing in cellular signaling, migration and wound repair | 1 | 2023 |
| R01GM135247 | Cross-species conservation of cell-type and single-cell specific isoform expression | 1 | 2023 |
| R01HD097665 | Spreading of Xist RNA and Polycomb complexes along the inactive X-chromosome. | 1 | 2023 |
| R01HG010485 | Enabling Comparative Pangenomics | 1 | 2023 |
| R01HG010759 | Computational methods for variant calling and haplotyping using long-read sequencing technologies | 1 | 2023 |
| R01HL082792 | Nuclear mechanics and mechanotransduction in muscular laminopathies | 1 | 2023 |
| R01HL128075 | Cardiomyopathy Genomes Project | 1 | 2023 |
| R01HL142879 | Molecular Control of Cardiomyocyte Mitophagy by the RhoGAP GRAF1 | 1 | 2023 |
| R01HL148338 | Reversal of Heart Failure: Role of Vascular Recovery | 1 | 2023 |
| R01HL152605 | COPII dependent regulation of T cell alloimmunity | 1 | 2023 |
| R01MH116950 | Neural Mechanisms of Sensory OverResponsivity | 1 | 2023 |
| R01NS051630 | Molecular Basis of rCGG-Mediated Neurodegeneration | 1 | 2023 |
| R01NS075233 | Molecular determinants and function of axonal actin assemblies | 1 | 2023 |
| R01NS086452 | Validation of Novel Pathogenic Post-Translational Modifications of Huntingtin, and of Modifying Enzymes as Therapeutic Targets for Huntington's Disease | 1 | 2023 |
| R01NS111978 | Pathophysiologic roles of alpha-synuclein at the synapse | 1 | 2023 |
| R01NS115903 | Proteostasis dysregulation and alpha-synuclein | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/grants?page=20